Monitoring BNP Expression and Cell Size to Determine Hypertrophic Response in Human Cardiomyocytes
28 Oct 2014

High-content imaging assays are a robust and useful tool for phenotypic screening processes used in both pharmacological testing and for drug development through disease modeling. In this application note, iCellR Cardiomyocytes, derived from human iPSCs, were used in an in vitro assay to illustrate detection of hypertrophy via increases in cell size and elevated levels of BNP. These cells have been shown to recapitulate the properties of native cardiomyocytes, and a disease model for hypertrophy was created by inducing cells with endothelin-1 (ET-1). The effectiveness of compounds for reducing hypertrophy was quantified using the automated ImageXpressR Micro High-Content Screening System and MetaXpressR Software to measure BNP expression and cell area.

Show    per page
1 of 5     Page  1 2 3  ... Next 
Good Westerns Gone Bad: Tips to Make Your NIR Western Blot Great24 Oct 2014Read
TR-FRET Based Transcreener AMP2/GMP2 Assay for Screening Ligases, Synthetases and Phosphodiesterases high throughput, targeted screening, kinase assays22 Oct 2014Read
Chromatrap® – Targeting the Epigenetic Landscape Alongside Low Abundant Transcription Factor Recruitment qPCR, epigenetics, immunoprecipitation25 Sep 2014Read
Enabling Epigenetics Studies from HTS to SAR: a Novel HTRF® Platform to Identify and Characterize Reader Domain Inhibitors epigenetics, high throughput, screening24 Sep 2014Read
Visualization and Characterization of Autophagosomes in Neuronal Cells Using Enhanced Imaging Techniques ELRIG, toxicity8 Sep 2014Read
Utilizing Two High Content Screening Assays; HCS-Phospholipidosis and HCS-Lysosomal Trapping and In Silico Modeling Approaches in Predicting In Vivo Phospholipidosis in vitro, compound screening4 Sep 2014Read
Evaluation of High Content Mechanism Screening as a Prediction Tool for Organ Toxicity cytotoxicity, drug development, high content imaging3 Sep 2014Read
Use of Physiologically-Based Pharmacokinetic Modeling (PBPK) in Conjunction with CellCiphr HCS to Predict Compound Safety Thresholds and Improve Lead Optimization drug development, pharmacokinetics, lead optimization2 Sep 2014Read
Better Antibody Screening: Reduce Costs. Reduce False Negatives. Improve Success therapeutic antibodies, screening15 Jul 2014Read
Implementation of Cisbio's HTRF® M1 muscarinic receptor related assays on CyBio liquid handling solutions for small and high throughput automation, high throughput, screening26 Jun 2014Read

Popular tags in SelectScience

Buying guides